查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1602643

過敏性鼻炎治療藥物市場：按給藥途徑、藥物類別和應用分類 - 全球預測 2025-2030

Allergic Rhinitis Drugs Market by Route of Administration (Intranasal, Intraocular, Oral), Class of Drugs (Antihistamines, Immunotherapies, Intranasal Corticosteroids), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，過敏性鼻炎治療藥物市值為47.5億美元，預計到2024年將達到49.7億美元，複合年成長率為4.77%，到2030年將達到65.9億美元。

過敏性鼻炎治療市場包括治療藥物的開拓、製造和商業化，以控制過敏反應引起的打噴嚏、鼻塞、鼻癢和流鼻水等症狀。此領域包括抗組織胺、鼻用皮質類固醇、鼻減充血劑和免疫治療藥物。全球過敏性鼻炎的高盛行率迫切需要有效的治療解決方案，從而導致對處方藥和非處方藥的強勁需求。應用主要集中在緩解患者免受季節性和常年性過敏原的影響，最終用途集中在居家醫療和臨床環境中。市場成長是由都市區污染加劇、過敏管理意識增強以及給藥系統進步等因素所推動的。生技藥品開發和個人化醫療方法等創新正在成為充滿希望的機會。此外，將人工智慧整合到患者診斷和監測系統中可以提高治療方法的準確性。然而，新藥的高成本、長期使用的潛在副作用以及減緩醫藥品認證過程的嚴格監管限制等挑戰也阻礙了成長。克服這些障礙需要在具有成本效益的配方和增強的患者依從性模型方面進行創新。針對過敏反應特定途徑的新型製劑（例如針對 IgE 的生物製藥）的研究有望帶來巨大的變革潛力。由於存在多個全球和區域參與者，市場競爭仍然很激烈，需要持續的研發投資和廣泛的行銷策略。隨著環境條件和生活方式的選擇繼續加劇過敏性鼻炎的盛行率，探索未服務的地理區域並根據當地人口特徵量身定做產品可能會提供競爭優勢。

主要市場統計
基準年[2023] 47.5億美元
預測年份 [2024] 49.7億美元
預測年份 [2030] 65.9億美元
複合年成長率（%） 4.77%

市場動態：快速發展的過敏性鼻炎治療市場的關鍵市場洞察

供需的動態交互作用正在改變過敏性鼻炎治療藥物市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 過敏性鼻炎盛行率上升
    • 吸煙增加導致的生活方式改變會促進過敏性鼻炎
    • 由於滴鼻劑等各種給藥方法的出現，對過敏性鼻炎治療的需求增加
    • 對非處方藥的需求
  • 市場限制因素
    • 過敏性鼻炎症狀的特異性降低
  • 市場機會
    • 擴大過敏性鼻炎治療藥物的開發與商業化
    • 政府和組織加強提高對過敏性鼻炎的認知
  • 市場挑戰
    • 過敏性鼻炎沒有標準治療方法。

波特五力：駕馭過敏性鼻炎藥物市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對過敏性鼻炎治療藥物市場的影響

外部宏觀環境因素在塑造過敏性鼻炎治療藥物市場的表現動態中起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解過敏性鼻炎治療藥物市場的競爭狀況

過敏性鼻炎治療藥物市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣過敏性鼻炎治療市場供應商績效評估

FPNV 定位矩陣是評估過敏性鼻炎治療藥物市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪過敏性鼻炎治療藥物市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對過敏性鼻炎治療藥物市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 過敏性鼻炎盛行率增加
      • 由於吸煙增加，生活方式的改變增加，會促進過敏性鼻炎。
      • 鼻噴劑等不同給藥方法的出現增加了對過敏性鼻炎治療的需求。
      • 對非處方藥的需求
    • 抑制因素
      • 過敏性鼻炎症狀的特異性降低
    • 機會
      • 擴大過敏性鼻炎治療藥物的開發與商業化
      • 政府和組織加強努力，提高對過敏性鼻炎的認知
    • 任務
      • 過敏性鼻炎沒有標準治療方法。
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 過敏性鼻炎治療藥物市場：依給藥途徑

  • 鼻內
  • 眼
  • 口服
  • 胃腸外的

第7章 過敏性鼻炎治療藥物市場（依藥物類型）

  • 抗組織胺藥
  • 免疫療法
  • 鼻內皮質類固醇

第8章過敏性鼻炎治療藥物市場：依應用分類

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第9章北美和南美過敏性鼻炎治療藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區過敏性鼻炎治療藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章：歐洲、中東和非洲的過敏性鼻炎治療藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Adamis Pharmaceuticals
  • Alcon, Inc.
  • Apotex Inc.
  • Ascend Laboratories LLC by The Pharma Network, LLC
  • Dr. Reddy's Laboratories, Ltd.
  • Gland Pharma Limited
  • GlaxoSmithKline PLC
  • Hikma Pharmaceuticals PLC
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Sandoz International GmbH by Novartis AG
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Unichem Laboratories Ltd.
Product Code: MRR-436901065A11

The Allergic Rhinitis Drugs Market was valued at USD 4.75 billion in 2023, expected to reach USD 4.97 billion in 2024, and is projected to grow at a CAGR of 4.77%, to USD 6.59 billion by 2030.

The market for allergic rhinitis drugs encompasses the development, manufacturing, and commercialization of therapeutics designed to manage symptoms such as sneezing, nasal congestion, and itchy or runny nose caused by allergic reactions. This domain includes antihistamines, intranasal corticosteroids, decongestants, and immunotherapy drugs. Given the high prevalence of allergic rhinitis worldwide, the necessity for effective treatment solutions is paramount, contributing to a robust demand in both prescription and over-the-counter segments. Applications primarily focus on patient relief from seasonal allergens and perennial allergies, with end-use concentrated in home care settings and clinical environments. Market growth is driven by factors such as rising urban pollution, increasing awareness of allergy management, and advances in drug delivery systems. Innovations such as the development of biologics and personalized medicine approaches are emerging as promising opportunities. Additionally, the integration of AI in patient diagnosis and monitoring systems is enhancing the precision of therapy regimens. However, growth is also stifled by challenges like high costs associated with novel drugs, potential side effects of long-term medication use, and stringent regulatory constraints that can delay drug approval processes. The market requires innovation in cost-effective formulations and enhanced patient adherence models to overcome these hurdles. Research directed towards novel drug formulations that target specific pathways in the allergy response, such as biologic drugs targeting IgE, promises significant disruption potential. The nature of the market remains highly competitive due to the presence of multiple global and regional players, demanding continuous R&D investments and large-scale marketing strategies. As environmental conditions and lifestyle choices continue to exacerbate incidences of allergic rhinitis, exploring under-addressed geographical regions and tailoring products to local demographics can provide a competitive advantage.

KEY MARKET STATISTICS
Base Year [2023] USD 4.75 billion
Estimated Year [2024] USD 4.97 billion
Forecast Year [2030] USD 6.59 billion
CAGR (%) 4.77%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Allergic Rhinitis Drugs Market

The Allergic Rhinitis Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of allergic rhinitis
    • Increasing lifestyle changes attributes to growing use of tobacco promotes allergic rhinitis
    • Availability of different modes of administration such as nasal sprays increases demand for allergic rhinitis drugs
    • Demand for over-the-counter drugs
  • Market Restraints
    • Reduced specificity of symptoms for allergic rhinitis
  • Market Opportunities
    • Growing development and commercialization of allergic rhinitis drugs
    • Increasing government and organization initiatives to increase the awareness of allergic rhinitis
  • Market Challenges
    • No standard cure for allergic rhinitis

Porter's Five Forces: A Strategic Tool for Navigating the Allergic Rhinitis Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Allergic Rhinitis Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Allergic Rhinitis Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Allergic Rhinitis Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Allergic Rhinitis Drugs Market

A detailed market share analysis in the Allergic Rhinitis Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Allergic Rhinitis Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Allergic Rhinitis Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Allergic Rhinitis Drugs Market

A strategic analysis of the Allergic Rhinitis Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Allergic Rhinitis Drugs Market, highlighting leading vendors and their innovative profiles. These include Adamis Pharmaceuticals, Alcon, Inc., Apotex Inc., Ascend Laboratories LLC by The Pharma Network, LLC, Dr. Reddy's Laboratories, Ltd., Gland Pharma Limited, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc., Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation, Sandoz International GmbH by Novartis AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Unichem Laboratories Ltd..

Market Segmentation & Coverage

This research report categorizes the Allergic Rhinitis Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Route of Administration, market is studied across Intranasal, Intraocular, Oral, and Parenteral.
  • Based on Class of Drugs, market is studied across Antihistamines, Immunotherapies, and Intranasal Corticosteroids.
  • Based on Application, market is studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of allergic rhinitis
      • 5.1.1.2. Increasing lifestyle changes attributes to growing use of tobacco promotes allergic rhinitis
      • 5.1.1.3. Availability of different modes of administration such as nasal sprays increases demand for allergic rhinitis drugs
      • 5.1.1.4. Demand for over-the-counter drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Reduced specificity of symptoms for allergic rhinitis
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing development and commercialization of allergic rhinitis drugs
      • 5.1.3.2. Increasing government and organization initiatives to increase the awareness of allergic rhinitis
    • 5.1.4. Challenges
      • 5.1.4.1. No standard cure for allergic rhinitis
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Allergic Rhinitis Drugs Market, by Route of Administration

  • 6.1. Introduction
  • 6.2. Intranasal
  • 6.3. Intraocular
  • 6.4. Oral
  • 6.5. Parenteral

7. Allergic Rhinitis Drugs Market, by Class of Drugs

  • 7.1. Introduction
  • 7.2. Antihistamines
  • 7.3. Immunotherapies
  • 7.4. Intranasal Corticosteroids

8. Allergic Rhinitis Drugs Market, by Application

  • 8.1. Introduction
  • 8.2. Hospital Pharmacy
  • 8.3. Online Pharmacy
  • 8.4. Retail Pharmacy

9. Americas Allergic Rhinitis Drugs Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Allergic Rhinitis Drugs Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Allergic Rhinitis Drugs Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Adamis Pharmaceuticals
  • 2. Alcon, Inc.
  • 3. Apotex Inc.
  • 4. Ascend Laboratories LLC by The Pharma Network, LLC
  • 5. Dr. Reddy's Laboratories, Ltd.
  • 6. Gland Pharma Limited
  • 7. GlaxoSmithKline PLC
  • 8. Hikma Pharmaceuticals PLC
  • 9. Johnson & Johnson Services, Inc.
  • 10. Merck & Co., Inc.
  • 11. Mitsubishi Tanabe Pharma Corporation
  • 12. Sandoz International GmbH by Novartis AG
  • 13. Sun Pharmaceutical Industries Ltd.
  • 14. Teva Pharmaceutical Industries Ltd.
  • 15. Unichem Laboratories Ltd.

LIST OF FIGURES

  • FIGURE 1. ALLERGIC RHINITIS DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ALLERGIC RHINITIS DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ALLERGIC RHINITIS DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ALLERGIC RHINITIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ALLERGIC RHINITIS DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ALLERGIC RHINITIS DRUGS MARKET DYNAMICS
  • TABLE 7. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY INTRAOCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY IMMUNOTHERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY INTRANASAL CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. ALLERGIC RHINITIS DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. ALLERGIC RHINITIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2023